An interventional study of Generic Lifestyle Education and ToBrainHealth Personalised Digital Intervention in Brain Health Activities, Cognition and Prevention, sponsored by Institut Guttmann. Completed at 1 site in Spain. Open to participants aged 40 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-07.
Sponsored by Institut Guttmann · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 162 studies in Cognitive Dysfunction with a site in Spain — 44 open to participants now, 61 under way, 9 of them phase 3. Cognitive Dysfunction · Spain.
Among the 162 studies in Cognitive Dysfunction with a site in Spain, this one is the 53rd largest by enrollment of the 127 interventional ones that give a count, is one of 15 that started in 2026, is one of 91 with no phase, and was the 149th registered.
3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.
Browse Cognitive Dysfunction studies →44 of the 162 studies in Cognitive Dysfunction with a site in Spain are open now. Recruiting first, the newest first:
Consorci Sanitari de l'Alt Penedès i Garraf · Sites in Spain
Ages 70+
Biogipuzkoa Health Research Institute · Sites in Spain
Ages 18+
Consorci Sanitari de Terrassa · Sites in Spain
Ages 65+ · Healthy volunteers
Stichting International Registry for Alzheimer's Disease and other Dementias Foundation · Sites in Spain, Australia, Austria and 14 more countries
Ages 18+
Universidad Complutense de Madrid · Sites in Spain
Ages 65–85
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 751 Cognitive Dysfunction studies recruiting now, 361 (48%) set no upper age limit and 144 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.
This study: 40 Years to 70 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
162 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 19 · Phase 3 16 · Phase 4 3
First in 2004; this study’s year is marked. 15 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 120 is above the median of 64 across 2,804 interventional studies indexed under Cognitive Dysfunction.
Median enrollment 100 across the 127 interventional studies, 250 across the 35 observational. Of the 77 that completed or were terminated, 17 (22%) have results posted.
This tab as a report to print or save as PDF → With an account.
37 of 162 have an industry lead sponsor. The 10 most frequent:
Institut Guttmann is the lead sponsor of 19 studies on the registry; 6 are open to participants now.
Institut Guttmann has 2 studies filed under Cognitive Dysfunction — fewer than ten, so there is no comparison to draw.
14 of the studies in Cognitive Dysfunction with a site in Spain that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03887455Phase 3Eisai Inc.A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease | 2026-12-31 |
| NCT07802392Consorci Sanitari de TerrassaImmersive Nature-Based Wellbeing Program in Older Adults With Cognitive Impairment | 2026-11 |
| NCT07793682Althaia Xarxa Assistencial Universitària de ManresaEarly Neuropsychological Rehabilitation and Family Psychoeducation After Ischemic Stroke | 2026-11-25 |
| NCT06956794Consorci Sanitari de TerrassaMultimodal Training With Immersive Virtual Reality to Improve the Cognitive Health and Emotional Well-being of Older Women Living Alone | 2026-12-01 |
| NCT05289258Universidad de CórdobaUnified Barlow Protocol (UP) in Cancer Survivors for Cognitive Impairments | 2026-12-30 |
Add all 14 to your calendar (.ics) → With an account.
Among the 162 studies in Cognitive Dysfunction with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Ageing is associated with a rising burden of neurological disorders, particularly dementia, which are now the leading cause of disability worldwide. Many dementia cases could potentially be prevented by modifying lifestyle factors such as physical inactivity, unhealthy diet, poor sleep, low social engagement and psychological distress. The Barcelona Brain Health Initiative (BBHI), a longitudinal cohort of more than 6,000 adults aged 40-75 years, has shown substantial inter-individual variability in lifestyle and psychological profiles and has identified subgroups at higher risk for poorer brain health.
ToBrainHealth is an 8-week, three-arm controlled intervention nested within BBHI. It evaluates different levels of personalisation and support to optimise healthy lifestyle behaviours using the ToBrainHealth platform, a digital platform that delivers recommendations, collects self-reported behaviours and integrates data from wearable activity trackers.
A total of 120 BBHI volunteers classified as moderate- or high-risk based on previous lifestyle and psychological questionnaires will be selected (40 per arm). Allocation to study arms will be pseudo-randomised, stratified by age, sex, and lifestyle and psychological profiles.
The three groups are: (1) a control group receiving only generic, non-personalised education about healthy lifestyles and regular online questionnaires, without use of ToBrainHealth platform tailoring; (2) a digital personalised intervention group using ToBrainHealth platform to deliver tailored lifestyle recommendations, adaptive intervention strategies and remote asynchronous supervision, supported by data from questionnaires and wearables; and (3) a digital personalised intervention plus intensive health-coaching group, which receives the same ToBrainHealth platform-based programme plus structured, proactive support and supervision by health professionals to enhance motivation and adherence.
The primary outcome is adherence to the lifestyle intervention, operationalised as the percentage of recommended activities and goals achieved during the 8-week programme, based on platform's logs, questionnaires and wearable data. The study will test whether lifestyle and psychological profile increases adherence compared with generic education, and whether adding intensive coaching provides additional benefit (expected gradient: coaching > digital only > control).
Secondary outcomes include the clinical impact of the intervention on brain-health-related measures. All participants will undergo pre- and post-intervention assessments including a brief medical evaluation (vital signs and anthropometrics), a digital neuropsychological battery, and questionnaires on motivation, lifestyle and psychosocial variables. These data will be analysed together with existing BBHI longitudinal information to explore changes in cognitive performance, health status and psychological wellbeing, and to characterise patterns and predictors of adherence across intervention arms.
The trial will also assess feasibility and acceptability of ToBrainHealth platform as a remote monitoring and coaching tool for brain-health promotion. Results are expected to generate new knowledge on the role of psychological and lifestyle profiles in adherence, and to inform scalable, technology-supported, personalised interventions aimed at preserving brain health and reducing the long-term risk of cognitive decline in community-dwelling adults.
ToBrainHealth Intervention Trial - Three-arm personalised lifestyle optimisation study The ToBrainHealth intervention trial is an 8-week, three-arm controlled study designed to evaluate the impact of personalised, technology-supported strategies on adherence to healthy lifestyle recommendations in community-dwelling adults. The study is embedded in the Barcelona Brain Health Initiative (BBHI), a large longitudinal cohort that investigates determinants of brain health across ageing. The trial addresses a crucial challenge in brain-health promotion: despite strong evidence that modifiable lifestyle factors positively influence resilience and reduce the risk of cognitive decline, long-term adherence to lifestyle interventions remains low.
Background and Rationale Ageing is associated with increasing prevalence of neurological disorders, particularly dementia, which represent the leading cause of disability globally. Cognitive decline is not inevitable; \~20% of older adults maintain youthful cognitive performance, reflecting brain resilience processes. Research from the BBHI cohort (>6,000 adults aged 40-75 years) demonstrates that lifestyle quality, psychological wellbeing, sleep, social engagement and physical activity predict brain health trajectories. However, substantial variability exists between individuals.
To better understand this variability, latent profile analysis of lifestyle and psychosocial data from the BBHI cohort identified three behavioural-psychological profiles: High Risk, Moderate Risk and Low Risk. High- and Moderate-Risk individuals exhibit poorer habits and lower levels of protective traits such as sense of coherence, self-reflection or emotional wellbeing, all of which influence adherence. These profiles provide an empirical basis for targeted interventions.
Lifestyle interventions often fail due to barriers such as lack of personalisation, limited feedback, insufficient motivational support, technical difficulties, and fluctuating emotional states. Evidence shows that technology-supported programmes can enhance adherence when they provide clear guidance, personalised content, adaptive strategies, monitoring features, and-when appropriate-professional supervision. The ToBrainHealth digital solution operationalises this knowledge to deliver multimodal lifestyle recommendations tailored to each participant's psychological and behavioural profile.
Study Objectives
Primary objective:
To determine whether digital personalisation and professional coaching improve adherence to a lifestyle-optimisation intervention.
Secondary objectives:
Study Design This is a controlled, three-arm intervention trial lasting 8 weeks. A total of 120 participants will be selected from the BBHI cohort among those classified into the High-Risk and Moderate-Risk latent profiles based on recent lifestyle, personality, and psychological questionnaires. Sixty individuals from each risk profile will be randomly selected. They will then be pseudo-randomised, stratified by age and biological sex, and psychological profile into one of the three study arms (n=40 per arm). Allocation will be concealed until the first visit, where each participant receives the appropriate study documentation.
Intervention Arms
Personalised Digital Intervention - ToBrainHealth platform (no personal coach)
Participants use the ToBrainHealth platform, a technology-based solution developed by Institut Guttmann and the Universidad Politécnica de Madrid, which allows:
Participants also wear a Fitbit HR device, synchronised with the platform to collect activity and sleep metrics. The device is loaned exclusively for study participation and must be returned upon completion.
Outcome Measures Primary Outcome: Adherence
Adherence is quantified as the percentage of recommended lifestyle actions completed during the 8-week intervention. The study will evaluate:
Secondary Outcomes: Clinical Impact and Behavioural Change
Before and after the 8-week intervention, all participants undergo standardised assessments, including:
Medical evaluation
Motivational and lifestyle assessment
- Used to refine personalised recommendations and characterise motivational profiles.
Results from these evaluations will be integrated with the extensive longitudinal information already available from the BBHI cohort, allowing analysis of changes in cognitive performance, psychological wellbeing and lifestyle patterns.
Sample Size and Statistical Considerations The total sample size (n=120) reflects power calculations based on expected small-to-moderate intervention effects (d≈0.3) observed in previous coaching-based lifestyle studies. With α=0.05 and power of 80%, the required sample is \~110 participants; 120 are recruited to compensate for an estimated 10% attrition rate. Planned analyses include repeated-measures ANOVAs and general linear models to compare intervention effects within and between groups.
Data Management and Confidentiality All data will be managed using dedicated REDCap electronic case-report forms. Data will be pseudonymised using unique participant codes. Identifiable information will be stored separately with restricted access and password-protected systems. Audit trails will document all modifications. Data export for statistical analysis will follow controlled procedures and comply with GDPR (Regulation EU 2016/679) and Spanish data-protection legislation (LO 3/2018). Fitbit data synchronisation requires explicit participant authorisation.
Regular data backups and REDCap system audits are performed at Institut Guttmann to guarantee data integrity and security.
Ethical Considerations Participants receive detailed written and verbal information about the study, including procedures, duration, potential risks, benefits, and data-protection safeguards. Participation is voluntary, and withdrawal may occur at any moment without explanation or consequences. No participant can be included without providing signed informed consent. The study protocol is submitted to the corresponding Research Ethics Committee (CER) prior to initiation, and any non-administrative protocol amendments require CER approval.
Implementation Schedule
The project includes:
Expected Scientific and Societal Impact The ToBrainHealth digital solution aims to advance understanding of resilience mechanisms and behaviour-change processes relevant to brain health. By combining personalisation, remote monitoring, digital phenotyping and intensive coaching, the study aspires to produce evidence-based, scalable strategies for maintaining brain health across the lifespan. Findings are expected to inform the development of personalised preventive programmes and guide public-health approaches aimed at reducing long-term risk of cognitive decline in ageing populations.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants receive general, non-personalised educational materials about healthy lifestyle habits, including information on nutrition, physical activity, sleep, cognitive stimulation and psychological wellbeing. They do not receive personalised recommendations nor access to adaptive features of the ToBrainHealth platform. Participants complete periodic online questionnaires to report their activities, but no tailored guidance or coaching is provided.
Behavioral: Generic Lifestyle Education
Participants use the ToBrainHealth digital platform, which provides personalised lifestyle recommendations based on individual behavioural and psychological profiles. The platform delivers adaptive intervention strategies, remote asynchronous monitoring and feedback. Participants also wear a Fitbit HR device that synchronises activity and sleep data with the platform. No human coaching is provided; all support is delivered digitally through the platform's personalised features.
Behavioral: ToBrainHealth Personalised Digital Intervention
Participants receive the full personalised digital intervention described for Arm 2, including tailored recommendations, adaptive strategies, digital monitoring and wearable integration. In addition, they receive intensive professional health coaching throughout the 8-week programme. Coaching sessions aim to enhance motivation, address barriers to behaviour change, reinforce adherence and optimise long-term adoption of healthy lifestyle habits.
Behavioral: ToBrainHealth Personalised Digital Intervention with Coaching
Participants receive non-personalized educational materials about healthy lifestyle habits related to brain health. They complete periodic questionnaires but do not receive individualized recommendations, adaptive digital support, or coaching. This condition serves as a comparison group to evaluate the added benefit of personalized digital interventions.
This intervention uses the ToBrainHealth digital platform to deliver personalised lifestyle recommendations and adaptive behaviour-change strategies based on each participant's psychological and behavioural profile. The platform integrates data from a Fitbit HR wearable to monitor activity and sleep. Guidance and monitoring are entirely digital, with no human coaching provided.
This intervention includes the full personalised digital program described above, enhanced with intensive, structured health coaching delivered by trained professionals. Coaching sessions aim to support motivation, address individual barriers, and reinforce adherence to lifestyle recommendations. This arm allows assessment of the added value of professional guidance beyond digital personalisation alone.
Adherence to Recommended Healthy Lifestyle Activities
Adherence will be defined as the percentage of recommended healthy lifestyle activities (e.g., physical activity, cognitive training, sleep routines, social and psychological exercises) that each participant completes during the 8-week intervention. It will be calculated from ToBrainHealth platform logs, self-reported questionnaires and Fitbit HR data, summarised as an overall adherence score for each participant and compared across intervention arms.
Time frame: From baseline to the end of the 8-week intervention period.
Plan to share: No — Individual participant data (IPD) will not be shared publicly at this stage. The dataset contains sensitive health and neuropsychological information, and full anonymization without risk of re-identification cannot be guaranteed. In addition, participant consent does not currently include provisions for broad data sharing. Aggregated results will be made publicly available through publications and reports. Future data sharing with qualified researchers may be considered upon reasonable request, subject to ethical approval, data protection regulations, and appropriate data-use agreements.
No publications or documents are linked to this record.
Ran from Feb 2026 to primary completion in Jul 2026, 4 months.
Of 1,453 non-industry interventional studies with no phase under Cognitive Dysfunction, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 51. This study's 4 months is below that.
Counting every sponsor, half of 1,522 studies reached it within 27 months; a quarter within 12 and three quarters within 50.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Institut Guttmann